{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:03:34Z","timestamp":1779674614078,"version":"3.53.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017694","name":"Guilin Scientific Research and Technology Development Plan","doi-asserted-by":"publisher","award":["20230135-1-1"],"award-info":[{"award-number":["20230135-1-1"]}],"id":[{"id":"10.13039\/501100017694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460158"],"award-info":[{"award-number":["82460158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","award":["Guike AB25069043"],"award-info":[{"award-number":["Guike AB25069043"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2023GXNSFAA026169"],"award-info":[{"award-number":["2023GXNSFAA026169"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04449-4","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T03:35:31Z","timestamp":1775964931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unlocking caspase-8 enables Pt(IV) to trigger robust caspase-3\/GSDME-mediated pyroptosis via drug co-delivery in chemoresistant bladder cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Jintao","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baotong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,12]]},"reference":[{"issue":"1","key":"4449_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71(1):96. https:\/\/doi.org\/10.1016\/j.eururo.2016.06.010.","journal-title":"Eur Urol"},{"issue":"3","key":"4449_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/jco.20.01665","volume":"39","author":"JWF Catto","year":"2021","unstructured":"Catto JWF, Gordon K, Collinson M, et al. Radical cystectomy against intravesical BCG for high-risk high-grade nonmuscle invasive bladder cancer: results from the randomized controlled BRAVO-feasibility study. J Clin Oncol. 2021;39(3):202. https:\/\/doi.org\/10.1200\/jco.20.01665.","journal-title":"J Clin Oncol"},{"issue":"17","key":"4449_CR3","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1200\/jco.2000.18.17.3068","volume":"18","author":"H von der Maase","year":"2000","unstructured":"von der Maase H, Hansen SW, Roberts JT, et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol. 2000;18(17):3068. https:\/\/doi.org\/10.1200\/jco.2000.18.17.3068.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4449_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","volume":"84","author":"M Roupr\u00eat","year":"2023","unstructured":"Roupr\u00eat M, Seisen T, Birtle AJ, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol. 2023;84(1):49. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.013.","journal-title":"Eur Urol"},{"issue":"44","key":"4449_CR5","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.2174\/1381612822666160831101529","volume":"22","author":"ME Hardie","year":"2016","unstructured":"Hardie ME, Kava HW, Murray V. Cisplatin analogues with an increased interaction with DNA: prospects for therapy. Curr Pharm Des. 2016;22(44):6645. https:\/\/doi.org\/10.2174\/1381612822666160831101529.","journal-title":"Curr Pharm Des"},{"issue":"7","key":"4449_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrurol.2014.129","volume":"11","author":"W Choi","year":"2014","unstructured":"Choi W, Czerniak B, Ochoa A, et al. Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer. Nat Rev Urol. 2014;11(7):400. https:\/\/doi.org\/10.1038\/nrurol.2014.129.","journal-title":"Nat Rev Urol"},{"issue":"7661","key":"4449_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547(7661):99. https:\/\/doi.org\/10.1038\/nature22393.","journal-title":"Nature"},{"issue":"3","key":"4449_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.semcancer.2022.03.009","volume":"86","author":"X Niu","year":"2022","unstructured":"Niu X, Chen L, Li Y, Hu Z, He F. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: perspectives for immunotherapy of SCLC. Semin Cancer Biol. 2022;86(3):273. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.009.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"4449_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5483\/BMBRep.2023-0024","volume":"56","author":"M Choi","year":"2023","unstructured":"Choi M, Shin J, Lee CE, et al. Immunogenic cell death in cancer immunotherapy. BMB Rep. 2023;56(5):275. https:\/\/doi.org\/10.5483\/BMBRep.2023-0024.","journal-title":"BMB Rep"},{"key":"4449_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115323","volume":"206","author":"AMP Romani","year":"2022","unstructured":"Romani AMP. Cisplatin in cancer treatment. Biochem Pharmacol. 2022;206:115323. https:\/\/doi.org\/10.1016\/j.bcp.2022.115323.","journal-title":"Biochem Pharmacol"},{"issue":"13","key":"4449_CR11","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1056\/NEJMoa2002788","volume":"383","author":"T Powles","year":"2020","unstructured":"Powles T, Park SH, Voog E, et al. Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma. N Engl J Med. 2020;383(13):1218. https:\/\/doi.org\/10.1056\/NEJMoa2002788.","journal-title":"N Engl J Med"},{"issue":"6","key":"4449_CR12","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","volume":"21","author":"M Yin","year":"2016","unstructured":"Yin M, Joshi M, Meijer RP, et al. Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis. Oncologist. 2016;21(6):708. https:\/\/doi.org\/10.1634\/theoncologist.2015-0440.","journal-title":"Oncologist"},{"key":"4449_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.biopha.2018.02.020","volume":"101","author":"C Urfali-Mamatoglu","year":"2018","unstructured":"Urfali-Mamatoglu C, Kazan HH, G\u00fcnd\u00fcz U. Dual function of programmed cell death 10 (PDCD10) in drug resistance. Biomed Pharmacother. 2018;101:129. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.020.","journal-title":"Biomed Pharmacother"},{"key":"4449_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2025.110497","volume":"771","author":"H Ling","year":"2025","unstructured":"Ling H, Xiao S, Lei Y, et al. The advancement of ubiquitination regulation in apoptosis, ferroptosis, autophagy, drug resistance and treatment of cancer. Arch Biochem Biophys. 2025;771:110497. https:\/\/doi.org\/10.1016\/j.abb.2025.110497.","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"4449_CR15","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/s41589-024-01584-7","volume":"20","author":"ME Honeywell","year":"2024","unstructured":"Honeywell ME, Isidor MS, Harper NW, et al. Functional genomic screens with death rate analyses reveal mechanisms of drug action. Nat Chem Biol. 2024;20(11):1443. https:\/\/doi.org\/10.1038\/s41589-024-01584-7.","journal-title":"Nat Chem Biol"},{"key":"4449_CR16","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.187448","author":"H Du","year":"2025","unstructured":"Du H, Liu HJ, Losko M, et al. Mitochondrial metabolic rewiring sensitizes mTORC1 inhibitor persister cells to cuproptosis. JCI Insight. 2025. https:\/\/doi.org\/10.1172\/jci.insight.187448.","journal-title":"JCI Insight"},{"issue":"5","key":"4449_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.04.010","volume":"43","author":"M Wang","year":"2025","unstructured":"Wang M, Chen X, Tan P, et al. Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer. Cancer Cell. 2025;43(5):985. https:\/\/doi.org\/10.1016\/j.ccell.2025.04.010.","journal-title":"Cancer Cell"},{"issue":"1","key":"4449_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2015.7","volume":"16","author":"SM Man","year":"2016","unstructured":"Man SM, Kanneganti TD. Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat Rev Immunol. 2016;16(1):7. https:\/\/doi.org\/10.1038\/nri.2015.7.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"4449_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1883-8","volume":"10","author":"X Xia","year":"2019","unstructured":"Xia X, Wang X, Cheng Z, et al. The role of pyroptosis in cancer: pro-cancer or pro-\"host\"? Cell Death Dis. 2019;10(9):650. https:\/\/doi.org\/10.1038\/s41419-019-1883-8.","journal-title":"Cell Death Dis"},{"issue":"7575","key":"4449_CR20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660. https:\/\/doi.org\/10.1038\/nature15514.","journal-title":"Nature"},{"issue":"7610","key":"4449_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature18590","volume":"535","author":"J Ding","year":"2016","unstructured":"Ding J, Wang K, Liu W, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;535(7610):111. https:\/\/doi.org\/10.1038\/nature18590.","journal-title":"Nature"},{"issue":"3","key":"4449_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","volume":"20","author":"P Broz","year":"2020","unstructured":"Broz P, Pelegr\u00edn P, Shao F. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2020;20(3):143. https:\/\/doi.org\/10.1038\/s41577-019-0228-2.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"4449_CR23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","volume":"27","author":"SB Kovacs","year":"2017","unstructured":"Kovacs SB, Miao EA. Gasdermins: effectors of pyroptosis. Trends Cell Biol. 2017;27(9):673. https:\/\/doi.org\/10.1016\/j.tcb.2017.05.005.","journal-title":"Trends Cell Biol"},{"issue":"8","key":"4449_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.492","volume":"11","author":"T Du","year":"2021","unstructured":"Du T, Gao J, Li P, et al. Pyroptosis, metabolism, and tumor immune microenvironment. Clin Transl Med. 2021;11(8):e492. https:\/\/doi.org\/10.1002\/ctm2.492.","journal-title":"Clin Transl Med"},{"issue":"1","key":"4449_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","volume":"13","author":"M Obeid","year":"2007","unstructured":"Obeid M, Tesniere A, Ghiringhelli F, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med. 2007;13(1):54. https:\/\/doi.org\/10.1038\/nm1523.","journal-title":"Nat Med"},{"issue":"12","key":"4449_CR26","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, Garg AD, Kaczmarek A, et al. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12(12):860. https:\/\/doi.org\/10.1038\/nrc3380.","journal-title":"Nat Rev Cancer"},{"issue":"7799","key":"4449_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41586-020-2079-1","volume":"579","author":"Q Wang","year":"2020","unstructured":"Wang Q, Wang Y, Ding J, et al. A bioorthogonal system reveals antitumour immune function of pyroptosis. Nature. 2020;579(7799):421. https:\/\/doi.org\/10.1038\/s41586-020-2079-1.","journal-title":"Nature"},{"issue":"1","key":"4449_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02344-4","volume":"24","author":"C Huang","year":"2025","unstructured":"Huang C, Li J, Wu R, Li Y, Zhang C. Targeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives. Mol Cancer. 2025;24(1):131. https:\/\/doi.org\/10.1186\/s12943-025-02344-4.","journal-title":"Mol Cancer"},{"key":"4449_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.biochi.2021.06.014","volume":"189","author":"EM Quistgaard","year":"2021","unstructured":"Quistgaard EM. Erratum to \u201cBAP31: Physiological functions and roles in disease\u201d. [BIOCHIMIE 186C (2021) 105\u2013129]. Biochimie. 2021;189:168. https:\/\/doi.org\/10.1016\/j.biochi.2021.06.014.","journal-title":"Biochimie"},{"issue":"8","key":"4449_CR30","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2174\/1567201813666160418105703","volume":"13","author":"B Yang","year":"2016","unstructured":"Yang B, Han X, Ji B, Lu R. Competition between tumor and mononuclear phagocyte system causing the low tumor distribution of nanoparticles and strategies to improve tumor accumulation. Curr Drug Deliv. 2016;13(8):1261. https:\/\/doi.org\/10.2174\/1567201813666160418105703.","journal-title":"Curr Drug Deliv"},{"key":"4449_CR31","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.2147\/ijn.S443168","volume":"19","author":"K Jakic","year":"2024","unstructured":"Jakic K, Selc M, Razga F, et al. Long-term accumulation, biological effects and toxicity of BSA-coated gold nanoparticles in the mouse liver, spleen, and kidneys. Int J Nanomedicine. 2024;19:4103. https:\/\/doi.org\/10.2147\/ijn.S443168.","journal-title":"Int J Nanomedicine"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04449-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04449-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04449-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T01:42:47Z","timestamp":1779673367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04449-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4449"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04449-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,12]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments complied with institutional guidelines and were approved by the Animal Ethics Committee of of Guilin Medical University (Approval No.GLMC20241012). The CT image in Figure. 1b was provided by The Second Affiliated Hospital of Guilin Medical University with written informed consent from patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and\u00a0consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"489"}}